introduction venomous snake one dangerous animal widely found world especially tropical region among venomous snake elapidae elapid viperidae viperids viper produce neurotoxin myotoxic agent respectively elapid naja kaouthia cobra ophiophagus hannah king cobra permanent front fang whereas viper including dabonia russellii russell viper trimeresurus albolabris green pit viper retractable front fang venom ejection snake venom contain numerous bioactive protein exhibit cytotoxicity toward several cell including neuron cell hematological cell myocytes several molecule snake venom new candidate modern medicine treatment example antihypertensive bradykinin vasodilator peptide south american pit viper anti-fibrinogen thrombin-like serine protease ischemic stroke brazilian pit viper anti-platelet three-finger toxin 3ftx indian cobra antimicrobial activity various proteinaceous compound snake venom antimicrobial multiple organism pseudomonas aeruginosa candida albicans staphylococcus aureus phospholipase pla2 -amino acid oxidase laao lebanon viper antimicrobial peptide cathelicidin multidrug-resistant acinetobacter baumannii methicillin-resistant aureus mrsa king cobra snake biofilms alteration free-living planktonic form bacteria sessile form self-secreted exopolysaccharide eps protecting organism antimicrobial agent one antibiotic resistance mechanism interestingly several anti-biofilms snake venom including prevention baumannii biofilms caatinga lancehead snake-isolated pla2 aureus biofilm eradication c-type lectin purified bothrops jararacussu south american pit viper however data anti-biofilms snake venom still especially aeruginosa biofilms either gram-positive gram-negative bacteria induce antibiotic resistance biofilm prevention eradication clinically useful especially patient indwelling catheter although anti-biofilms toward multi-organisms easy clinical use anti-biofilms individual organism demonstrated clearer mechanistic action due different mechanism biofilm production different microbe aeruginosa infection emerging health-care problem among several biofilm-producing pathogen partly due effective biofilm formation several strain demonstrated several chronic infection cystic fibrosis catheter-induced infection chronic wound anti- pseudomonas biofilms might beneficial exopolysaccharides eps pseudomonas biofilms consist alginate -mannuronic acid -guluronic acid polysaccharide psl neutral pentasaccharide subunit containing mannose rhamnose glucose controlled polysaccharide synthesis locus psl gene embedment sessile-formed bacteria biofilm substance responsible antimicrobial resistance despite vitro susceptibility antibiotic planktonic bacterial form patient retained catheter urinary venous peritoneal hemodialysis catheter biofilms cause several episode infection increased morbidity mortality profound polysaccharide component biofilms possible carbohydrate digestibility enzyme surface-bound glycoside hydrolase enzyme prevent psl attachment catheter surface effective pseudomonas biofilm prevention however snake venom fascinating source powerful enzyme might act mature biofilms especially catheter lock solution several indwelling catheter adjunctive antimicrobial agent evaluated anti-biofilm effect snake venom commonly found thailand identified possible effective enzyme pseudomonas biofilms might clinically beneficial result antimicrobial property crude snake venom especially hannah king cobra albolabris green pit viper broad-spectrum antimicrobial antimicrobial effect play crucial role biofilm eradication eradication dispersed cell screened antimicrobial property venom thai common snake including naja kaouthia cobra ophiophagus hannah king cobra dabonia russellii russell viper trimeresurus albolabris green pit viper vitro antimicrobial activity including minimum inhibitory concentration mics minimum bactericidal concentration mbcs performed gram-negative gram-positive bacteria maximum concentration crude venom 0.25 mg/ml avoid profound dilution bacterial medium much dilution bacterial broth see method section venom exhibited bacterial inhibition selected aeruginosa isolates mic range 0.06 0.25 mg/ml table contrast venom inhibit escherichia coli atcc mic 0.25 mg/ml among gram-positive bacteria growth aureus strain interfered four venom mic range 0.0038 0.25 mg/ml selected snake venom affect enterococcus faecalis mic 0.25 mg/ml venom bactericidal activity aeruginosa mbc range 0.06 0.25 mg/ml additionally venom exhibited bactericidal effect aureus mbc range 0.0038 0.25 mg/ml therefore snake venom effective aureus venom categorized broad-spectrum antimicrobial agent gram-positive aureus gram-negative bacteria aeruginosa table antimicrobial anti-biofilm biofilm eradication activity crude snake venom including naja kaouthia ophiophagus hannah dabonia russellii trimeresurus albolabris venom full size table crude snake venom exhibited anti-biofilm activity partially destroyed established biofilms due effect gram-positive gram-negative bacteria venom tested anti-biofilm activity inhibition biofilm formation determined minimum biofilm inhibitory concentration mbics venom mic mic twofold higher mic identical mbic range 0.06 0.25 mg/ml adequate prevent pseudomonas biofilm incubated venom together aeruginosa table moreover venom inhibited biofilms aureus atcc mbic 0.0038 mg/ml notably venom without antimicrobial effect exhibit anti-biofilm formation especially coli atcc three faecalis isolates table therefore biofilm prevention effect venom aeruginosa mainly due antimicrobial activity subsequently test ability snake venom eliminate biofilms administration venom onto preformed biofilms indicated minimum biofilm eradication concentration mbecs determined using bacterial-preformed biofilms 96-well culture plate although venom biofilm eradication effect mbecs higher 0.25 mg/ml venom prominently decreased preformed biofilms aeruginosa isolates including aeruginosa atcc aeruginosa strain pao1 pao1 standard strain used biofilm study together clinical-isolated aeruginosa pacl chlorhexidine-treated clinical isolated aeruginosa c_pacl supplementary fig contrast biofilm disruption effect venom preformed biofilm pseudomonas spp supplementary fig venom effective antimicrobial anti-biofilm aeruginosa venom investigated mechanistic experiment king cobra venom hannah reduced aeruginosa extracellular polysaccharide alginate psl partly regulation algu muca gaca aeruginosa pao1 standard strain pacl clinically isolated strain prominently produced biofilms selected strain strain tested sub-mic level venom lower mic level 0.5 mic biofilms crude oh-venom 0.5 mic 0.125 mg/ml reduced biofilms pao1 pacl fig a–c partly down-regulated algd pslb encoded gene alginate psl respectively biofilms fig d–g alginate component pseudomonas eps controlled algu/muca complex binding muca protein outer membrane negative regulator sigma factor algu impeding alginate synthesis fig interestingly crude venom downregulated algu fig muca fig sessile aeruginosa pao1 without effect pacl fig indicating decrease alginate production possibly algu inhibition early-stage biofilm strain-dependent manner meanwhile psl component pseudomonas eps regulated psl operon gacsa/rsma regulator fig venom downregulated gaca early mature biofilms aeruginosa pao1 pacl fig f–g hence crude venom demonstrated bactericidal impact planktonic aeruginosa table anti-biofilm activity partly downregulated gene alginate psl component synthesis fig figure anti-biofilm activity crude king cobra venom aeruginosa reference strain pao1 clinical strain pacl intensity crystal violet stain biofilms aeruginosa pao1 clinically isolated strain pacl cultured crude venom representative biofilm picture 96-well polystyrene plate stained crystal violet demonstrated expression gene encoding alginate psl synthesis including algd pslb determined biofilms aeruginosa cultured crude venom sub-mic level avoiding lethal effect venom qrt-pcr demonstrated experiment performed independent triplicate mean sem presented paired test analysis 0.05 full size image figure crude king cobra venom reduced production alginate psl aeruginosa reference strain pao1 clinical strain pacl down-regulation several gene diagram extracellular polysaccharide eps including alginate psl production aeruginosa including muca inactivation external stress resulting release free sigma factor algu switch alginate synthesis operon c-di-gmp-dependent psl synthesis via activation diguanylate cyclase siad c-di-gmp-independent pathway using rsmz regulated gaca regulator gene expression profile aeruginosa pao1 aeruginosa clinical isolated strain pacl biofilms cultured crude venom sub-mic level avoiding lethal effect venom alginate production including algu muca psl production gaca determined qrt-pcr demonstrated experiment performed independent triplicate mean sem presented paired test analysis ˂0.05 full size image -amino acid oxidase hannah venom oh-laao potential active substance antimicrobial anti-biofilm activity aeruginosa crude venom purified three-step chromatography see method section first step analytical gel filtration using sephadex g-75 column chromatography fig exploring effective fraction among 5-peaks eluted protein peak-1 elution demonstrated prominent bactericidal activity aeruginosa pao1 pacl mic mbc µg/ml table also showed prominent anti-biofilm effect biofilms biofilm prevention experiment fig b–e h-established biofilms biofilm eradication experiment fig f–i implying biofilm prevention biofilm detachment property result suggested antimicrobial anti-biofilms biofilm eradication effect venom peak-1 elution first step purification figure active peak-1 fraction crude king cobra venom anti-biofilm activity first step purification using sephadex g-75 column chromatography peak crude venom demonstrated including peak-1 fraction 5–6 peak-2 fraction peak-3 fraction 9–10 peak-4 fraction 11–14 peak-5 fraction 20–22 purified venom collected intensity crystal violet-stained biofilms aeruginosa pao1 aeruginosa clinically isolated strain pacl cultured peak purified venom µg/ml representative 96-well polystyrene plate demonstrated likewise intensity crystal violet stain h-preformed biofilms aeruginosa pao1 pacl cultured peak purified venom µg/ml representative 96-well polystyrene plate demonstrated experiment performed independent triplicate mean sem presented one-way anova followed tukey analysis 0.05 purification using three-step purification 3-column chromatography purified oh-laao demonstrated sds-page amino acid sequence purified oh-laao result showed coverage purified oh-laao -amino-acid oxidase hannah uniprot database p81383 matched peptide demonstrated red bold character full size image table antimicrobial anti-biofilm biofilm eradication activity ophiophagus hannah elution peak-1 peak-5 first step purification using sephadex g-75 column chromatography purified oh- -amino acid oxidase laao three-step purification full size table additionally specific laao activity peak remarkedly observed peak-1 11.17 1.31 u/mg supplementary fig second step peak-1 elution sephadex g-75 column chromatography separated purified laao enzyme using resource column chromatography showed peak elution supplementary fig peak-1 eluted resource column demonstrated remarkable laao activity 15.99 1.18 u/mg supplementary fig last step purification used hitrap™ heparin column chromatography see method section showed two peak elution supplementary fig highest laao activity observed peak-1 elution 21.72 1.39 u/mg supplementary fig summary using three-step purification provided significantly higher specific activity laao supplementary fig s10 table experiment approximately kda protein dominant peak-1 elution last step purification using hitrap™ heparin column chromatography fig identified -terminal amino acid sequence using nano-high performance liquid chromatography nano-hplc mass spectrometry database search see method section purified oh-laao matched laao submitted uniprot database uniprot database p81383 laao amino acid sequence fig purified oh-laao approximately kda higher molecular weight laao database p81383 55.977 kda indicating post-translation modification glycosylation oh-laao study therefore purified venom hitrap™ heparin column used oh-derived laao oh-laao purification oh-laao showed increased antimicrobial activity aeruginosa pao1 pacl µg/ml mics mbcs respectively table µg/ml purified oh-laao exhibited prominent anti-biofilm effect table subsequently impact purified oh-laao aeruginosa biofilms investigated 2.5 µg/ml purified oh-laao 0.5 mic downregulated algd pao1 pacl planktonic sessile form pslb downregulated sessile planktonic cell algu downregulated sessile form fig a–f similar pslb downregulation gaca rsmz small rna downstream transcribed gaca system downregulated fig g–j additionally expression siad encoded diguanylate cyclase c-di-gmp production positive psl regulator depleted pao1 pacl fig k–l figure prevention biofilm synthesis -amino acid oxidase hannah venom oh-laao gene expression profile planktonic non-biofilm sessile biofilm form aeruginosa pao1 aeruginosa clinically isolated strain pacl biofilms cultured oh-laao sub-mic level avoiding lethal effect alginate algd psl production pslb regulator including algu gaca rsmz siad determined qrt-pcr demonstrated experiment performed independent triplicate mean sem presented paired test analysis 0.05 full size image biofilm eradication experiment h-preformed biofilms purified oh-laao downregulated algd pslb gaca rsmz siad pao1 pacl downregulated fleq flagellar regulator gene pacl fig a–f indicating possible biofilm erosion reduced c-di-gmp pao1 pacl decreased motility pacl one anti-biofilm mechanism therefore anti- pseudomonas biofilms purified oh-laao demonstrated reduced synthesis alginate psl component biofilms especially gaca/ rsmz c-di-gmp-related mechanism figure eradication preformed biofilms -amino acid oxidase hannah venom oh-laao gene expression profile preformed biofilms aeruginosa pao1 aeruginosa clinically isolated strain pacl incubation oh-laao mic level alginate algd psl production pslb regulator including gaca rsmz siad fleq encoding transcriptional regulator controlling gene flagellum determined qrt-pcr demonstrated experiment performed independent triplicate mean sem presented paired test analysis 0.05 full size image -amino acid oxidase hannah venom oh-laao demonstrated antimicrobial anti-biofilm activity mediated production one hydrolysis enzyme oh-laao induces several metabolite including 2-oxocarboxylate ammonium hydrogen peroxide substrate -amino acid fig incubation oh-laao either -lysine -arginine increased antimicrobial impact pao1 planktonic compared oh-laao alone indicated growth inhibition plate time-kill assay fig b–c antimicrobial property oh-laao neutralized catalase decomposing enzyme fig d–e likewise catalase also neutralized anti-biofilm effect oh-laao determined crystal violet staining rescue several biofilm-associated gene including algd pslb algu gaca siad pao1 pacl difference strain fig a–g aeruginosa environment sensing protein nbda recognize several activator including nitric oxide promote several phosphodiesterase enzyme pdes bdla dipa c-di-gmp degradation enhanced biofilm matrix-degrading enzyme including enda pslg hydrolyzer extracellular dna edna psl hydrolyzer respectively resulting biofilm dispersion natural process biofilm biomass reduction fig oh-laao promoted biofilm dispersion enhanced expression nbda bdla dipa enda pslg neutralized catalase fig b–f suggesting -mediated mechanism nbda/bdla/dipa axis activation enda pslg matrix-degrading enzyme data implied crucial role enzyme metabolite especially antimicrobial anti-biofilm property oh-laao figure antimicrobial activity -amino acid oxidase hannah venom oh-laao hydrogen peroxide -dependent mechanism diagram -amino acid oxidase laao enzymatic reaction growth inhibition plate assay graph representative picture time-kill assay using oh-laao 0.025–0.1 µg/spot without substrate -arginine -lysine 2.5 mm/spot aeruginosa pao1 demonstrated also effect catalase hydrogen peroxide decomposer either crude venom oh-laao aeruginosa pao1 aeruginosa clinical isolated strain pacl microbicidal activity also indicated experiment performed triplicate data presented mean sem one-way anova followed tukey analysis 0.05 0.05 full size image figure anti-biofilm activity -amino acid oxidase hannah venom oh-laao hydrogen peroxide -dependent mechanism intensity crystal violet stain biofilms aeruginosa pao1 aeruginosa clinically isolated strain pacl cultured oh-laao without catalase representative biofilm picture 96-well polystyrene plate stained crystal violet demonstrated gene expression profile sessile cell aeruginosa pao1 pacl cultured oh-laao without catalase alginate algd psl production pslb regulator including algu gaca siad determined qrt-pcr also demonstrated experiment performed independent triplicate mean sem presented one-way anova followed tukey analysis 0.05 full size image figure biofilm dispersion activity -amino acid oxidase hannah venom oh-laao hydrogen peroxide -dependent mechanism diagram biofilm dispersion aeruginosa external stimulation factor including nitric oxide activate nbda no-induced biofilm dispersion promote chemotaxis protein bdla stimulates phosphodiesterase enzyme dipa rbda resulting decreased c-di-gmp level enhancement biofilm matrix-degrading enzyme enda pslg expression biofilm dispersion-related gene including nbda bdla dipa gene biofilm matrix-degrading enzyme including enda pslg determined qrt-pcr oh-laao incubation without catalase preformed biofilms aeruginosa pao1 aeruginosa clinical isolated strain pacl demonstrated experiment performed independent triplicate mean sem presented one-way anova followed tukey analysis 0.05 considered statistically significant full size image discussion antimicrobial anti-biofilm -amino acid oxidase hannah venom oh-laao mediated metabolite aeruginosa biofilms composition crude snake venom depends specie interspecies variation geological habitat intraspecies variation 3ftx king cobra venom indonesia malaysia substance respectively pla2 malaysian thai cobra total compound respectively hence isolation synthesis active molecule snake venom overcome variation coli faecalis resistant venom bacteria isolated venom snakebite wound indicating possible natural resistance microbial evolution however aeruginosa minor microbiota snake oral cavity biofilm production property pathogenicity susceptible several snake venom especially king cobra venom although venom exhibited broad spectrum antimicrobial activity indicated mics mbcs table venom prominent eradication pseudomonas biofilms supplementary fig although venom selected snake purified oh-laao could entirely eradicate biofilms indicated high mbec level table venom oh-laao demonstrated impact biofilms indicated acceptable mbic value indeed -amino acid oxidase laaos enzyme produced many living organism identified potentially effective compound venom antimicrobial anti-biofilm property partly hydrogen peroxide production although laaos various -amino acid substrate especially -leucine laao king cobra oh-laao seems specific -lysine -arginine indeed snake laaos rapidly strongly produce human laaos encoded interleukin-4-induced gene il4i1 human laaos induced higher indole-3-pyruvate i3p promotes cancer survival due difference laaos snake host -lysine -arginine possibly specific oh-laao used study despite neutralization several anti-oxidants living cell laao venomous animal produce high induce damage cell -mediated cell surface injury overcome gene-mediated antibiotic resistance engineering laaos specific bacterial cell interesting combating pan-drug-resistant bacteria especially aeruginosa adverse effect host cell notably sub-lethal oh-laao used anti-biofilm experiment avoid interference microbicidal activity demonstrable anti-biofilm property direct effect anti-biofilms simple antimicrobial activity although several sub-lethal stress oxidative stress ultraviolet also enhance alginate psl production aeruginosa biofilms level oh-laao might high enough induce bacterial adverse effect likewise laao benefit pseudomonas biofilms also supported escapin laao derived ink sea hare generation several intermediate product -amino acid oxidase hannah venom oh-laao versus several gene-associated aeruginosa biofilms harsh environment pseudomonas biofilm synthesis initiated alginate synthesis alg operon expression release sigma factor algu muca algu negative regulator psl production psl operon activation c-di-gmp dependent process diguanylate cyclase siad gaca transcriptional regulator rsmz non-coding small rna pathway oh-laao inhibited biofilm production dependent manner effect neutralized catalase neutralizing enzyme concluded fig left side moreover oh-laao attenuated pre-formed biofilm partly induced biofilm dispersion reduced biofilm biomass conversion sessile planktonic bacteria separated biofilms biofilm dispersion initiated nbda activated regulatory sensor trigger phosphodiesterases bdla dipa digest c-di-gmp inducing degradation extracellular dna edna psl important biofilm component endonuclease matrix-degrading enzyme pslg respectively indeed oh-laao promoted biofilm dispersion fig neutralized catalase suggesting -dependent mechanism concluded fig right side figure proposed diagram hydrogen peroxide -mediated anti-biofilm biofilm eradication -amino acid oxidase hannah venom oh-laao metabolite oh-laao play potent role anti-biofilm aeruginosa impairment biofilm matrix production including alginate psl reduced c-di-gmp level resulting weakened biofilm formation left side production biofilm eradication impact preformed biofilms trigger aeruginosa biofilm dispersion protein alleviate c-di-gmp level enhance biofilm matrix-degrading enzyme actively destroy biofilms right side full size image nevertheless limitation biofilm-degrading enzymatic treatment necessity multiple enzyme due numerous type eps biofilms different organism different eps composition step biofilm interestingly alone oh-laao suppressed several eps gene algd pslb enhanced numerous eps-degrading enzyme enda pslg without necessity enzyme combination suggesting potentially effective biofilm eradication although spreading infection dispersed cell biofilm oh-laao antimicrobial activity might reduce concern despite necessity vivo experiment oh-laao might useful prevention treatment biofilms catheter catheter-lock solution conclusion antimicrobial anti-biofilm activity crude venom aeruginosa possibly mainly due laao promoted -associated down-regulation several gene biofilm production moreover generated laao venom biofilm eradication activity via increased expression several gene biofilm dispersion extraction synthesis oh-laao clinically fascinating candidate anti-biofilms pseudomonas spp study interesting method bacterial strain crude snake venom clinically isolated strain aeruginosa pacl aureus sa1 sa2 sa3 faecalis ef1 ef2 ef3 isolated patient king chulalongkorn memorial hospital bangkok thailand method experimental protocol approved institutional review board faculty medicine chulalongkorn university irb 610/2564 accordance guideline declaration helsinki institutional biosafety committee mdcu-ibc001/2022 biosafety guideline chulalongkorn university waived informed consent irb 610/2564 parallel chlorhexidine digluconate-treated pacl c_pacl representative aeruginosa enhanced biofilms external stimulation anti-septic commercially available bacteria including aeruginosa atcc pao1 coli atcc aureus atcc also used hand crude freeze-dried venom isolated kaouthia hannah russellii albolabris obtained queen saovabha memorial institute thai red cross society bangkok thailand -amino acid oxidase laao purification venom crude venom purified three-step procedure column chromatography using äkta purification machine healthcare life science solingen germany identify potent fraction aeruginosa firstly crude venom mg/ml phosphate buffer saline 7.3 loaded sephadex g-75 column 3.2 healthcare life science eluted measured protein concentration absorbance mau fraction belonging peak pooled including peak-1 fraction 5–6 peak-2 fraction peak-3 fraction 9–10 peak-4 fraction 11–14 peak-5 fraction 20–22 peak determined laao activity mentioned later notably peak-1 first step demonstrated positive specific laao activity among peak 11.17 1.31 u/mg secondly peak-1 elution sephadex g-75 column chromatography concentrated dialyzed tris–hcl 8.0 concentrated peak-1 elution subsequently purified using resource column column healthcare life science equilibrated tris–hcl 8.0 eluted linear gradient using 0–1 sodium chloride nacl tris–hcl 8.0 measuring protein concentration resource column fraction belong peak including peak-1 fraction 12–13 peak-2 fraction peak-3 fraction 15–17 pooled laao activity determination mentioned later peak-1 eluted resource column chromatography second step showed highest specific laao activity among three peak 15.99 1.22 u/mg thirdly peak-1 resource column chromatography concentrated dialyzed tris–hcl 8.0 purification third step purification briefly concentrated peak-1 loaded equilibrated hitrap™ heparin affinity chromatography column 1.6 2.5 healthcare life science tris–hcl 8.0 eluted linear gradient using 0–1 nacl tris–hcl 8.0 protein eluted fraction measured two peak including peak-1 fraction 3–7 peak-2 fraction 20–22 observed collected laao activity assay mentioned peak-1 peak-2 third step purification peak-1 showed greatest specific laao activity 21.72 1.39 u/mg used experiment purified oh-laao -amino acid oxidase laao activity test crude venom purified fraction mentioned determined laao activity using -leucine substrate standard enzymatic assay previously described slight modification briefly 0.5 substrate solution containing triethanolamine solution sigma-aldrich usa 0.4 -leucine sigma chemical usa 0.0065 -dianisidine sigma-aldrich added 0.007 horseradish peroxidase sigma-aldrich sample start enzymatic reaction substrate oxidative activity measured increased absorbance every min one unit laao enzyme activity defined oxidation µmole -leucine per min protein concentration sample determined bradford assay thermo fisher scientific usa standard protein using bovine serum albumin bsa sigma-aldrich laao enzyme activity calculated using following equation laao\ enzyme\ activity u/ml a436\ total\ volumn\ of\ the\ assay volumn\ of\ the\ sample increased absorbance per minute molecular extinction coefficient laao reaction product specific laao activity calculated using following equation specific\ laao\ enzyme\ activity u/mg laao\ enzyme\ activity u/ml the\ amount\ of\ protein mg/ml identification isolated -amino acid oxidase venom oh-laao laao identification purified fraction hitrap™ heparin column chromatography separated sodium dodecyl-sulfate polyacrylamide gel electrophoresis sds-page analysis briefly protein separated polyacrylamide gel electrophoresis min followed staining coomassie brilliant blue cbb de-staining coomassie brilliant blue de-staining solution gel photo captured using camera approximately kda protein exhibited predominated protein band sds-page analysis protein processed n-terminal amino acid sequence brief eluted fraction positive laao activity hitrap™ heparin column treated trypsin sigma-aldrich usa overnight tryptic sample dried speedvac centrifuge room temperature dissolved 0.1 trifluoroacetic acid tfa loaded onto 3.5 column agilent zorbax 300sb-c18 agilent technology usa eluted linear gradient water/acetonitrile/0.1 formic acid v/v/v using shimadzu prominence nano-high performance liquid chromatography electrospray ionization time-of-flight mass spectrometer nano-hplc/esi-tof sciex usa mass spectrometry data submitted analyzed mascot sequence matching software matrix science usa using data uniprot database protein identification antimicrobial activity snake venom crude freeze-dried venom dissolved sterilized distilled water evaluated antimicrobial activity using broth microdilution assay briefly crude venom mg/ml added final volume broth difco usa 96-well plate maximum concentration crude venom 0.25 mg/ml avoid bacterial nourishment broth bacterial isolates final concentration cfu/well co-cultured broth supplemented two-fold serial dilution crude venom followed incubation minimal inhibitory concentration mics defined lowest concentration inhibits bacterial growth visually evaluated next bacterial growth broth microdilution method inoculated agar difco determine minimum bactericidal concentration mbcs mbcs lowest venom concentration kill bacteria resulting visible growth agar anti-biofilm activity testing biofilm prevention biofilm prevention bacteria cfu/ml cultured 96-well plate containing broth supplemented serial dilution either crude venom purified oh-laao incubation bacterial supernatant removed gently pipetting biofilms washed twice sterilized distilled water biofilms stained 0.1 crystal violet min washed twice minimum biofilm inhibitory concentration mbics defined lowest concentration inhibits bacterial biofilm formation visually evaluated cv-stained biofilms measured detection quantify biofilm mass biofilm eradication activity testing experiment preformed biofilms biofilm eradication activity either crude venom purified oh-laao tested using 24-h preformed bacterial biofilms bacteria cfu/ml grown 96-well plate broth bacterial supernatant containing bacterial planktonic form removed aseptically pipetting 24-h biofilms washed sterilized biofilms treated broth containing either snake venom purified oh-laao treatment remaining biofilms stained 0.1 crystal violet min washed twice minimum biofilm eradication concentration mbecs defined lowest concentration completely eradicates bacterial biofilm visually evaluated moreover remaining biofilms quantified measurement 590nm bacterial gene expression expression gene encoding biofilm-related protein aeruginosa determined quantitative real-time reverse transcription-polymerase chain reaction qrt-pcr using primer listed supplementary table briefly total rna planktonic bacteria without biofilms sessile bacteria biofilms form extracted trizol reagent invitrogen carlsbad usa converted cdna using revertaid first strand cdna synthesis kit thermo scientific vilnius lithuania number gene transcript quantified quantstudio6 applied biosystems foster city usa using sybr green pcr master mix applied biosystems relative number transcript normalized rrna calculated using −δδct method oh-laao -amino acid combination bacterial inhibition study substrate laao -amino acid combination oh-laao -amino acid used aeruginosa growth inhibition plate assay briefly lawn aeruginosa cfu/ml agar spotted oh-laao 0.025–0.1 µg/spot without -amino acid -lysine -arginine sigma chemical usa 2.5 mm/ spot incubation inhibition zone visually observed increased inhibition oh-laao -amino acid confirmed time-kill assay briefly aeruginosa cfu/ml grown broth supplemented oh-laao 0.5 mic without -amino acid -lysine -arginine shaking rpm viable bacterial cell min quantified drop plate method accordingly bacterial suspension diluted serially sterilized 0.85 nacl followed dropping agar quantify bacterial colony furthermore catalase hydrogen peroxide decomposer used time-kill study evaluate hydrogen peroxide potent antibacterial product oh-laao brief aeruginosa cfu/ml grown broth supplemented snake venom either crude venom oh-laao mic catalase 0.1 mg/ml sku yiwu china viable bacteria determined drop plate method described statistical analysis statistical analysis performed using statistical package social science software spss 22.0 spss inc. usa graph pad prism version 7.0 software jolla usa data presented mean standard error difference two group multiple group examined statistical significance paired -test one-way analysis variance anova tukey analysis respectively -value 0.05 considered statistically significant